How Nandrolone Phenylpropionate Affects Haematocrit

Nandrolone phenylpropionate delivers identical nandrolone to nandrolone decanoate, so the erythropoietic mechanism is shared:

1. EPO upregulation: Androgens increase renal erythropoietin production, signalling the bone marrow to produce more red cells. Nandrolone is potent enough at this that androgens including nandrolone were used clinically for the anaemia of chronic kidney disease before recombinant EPO became available, and the practice has been formally reviewed in the Cochrane literature (Yang et al., 2014, PMID 25300168).

2. Hepcidin suppression: Androgens suppress hepcidin, increasing iron absorption and mobilisation from stores and supplying the iron needed for haemoglobin synthesis.

3. Direct erythroid progenitor stimulation at the bone marrow.

4. Additive with the testosterone base: Nandrolone is almost always run alongside testosterone, and both stimulate erythropoiesis. A haematocrit problem on an NPP cycle is a combined problem, and reducing either compound helps.

What the ester changes: the phenylpropionate ester has a half-life of roughly 2 to 3 days versus 6 to 12 days for decanoate. Steady state is reached within about a week, so haematocrit begins climbing sooner. More usefully, clearance takes days rather than weeks, so if haematocrit crosses the intervention threshold, stopping the compound produces a response on a useful timescale.

Injection frequency: The short ester requires injections every other day or every third day. That frequency also means lower peak concentrations for a given weekly dose, which mildly blunts the erythropoietic drive compared with a large infrequent injection.

Typical doses (300-600 mg/week, usually alongside testosterone):

• Haematocrit commonly rises 3 to 7 percentage points over a cycle
• Values above 54% are reported, particularly on longer runs and in men who already sat above 50% at baseline
• The combined effect with a testosterone base exceeds what either produces alone

Timeline with the short ester:

• Steady state within about a week
• Haematocrit begins rising by week 3 to 4 and continues through the cycle
• After the last injection, the compound clears within days and haematocrit begins falling within 2 to 3 weeks, reaching baseline over 6 to 10 weeks

Compared with decanoate: the decanoate ester keeps releasing for weeks, so haematocrit can continue climbing after you stop. NPP does not have this problem, which is a genuine practical advantage for anyone with a haematocrit history.

Symptoms of a high haematocrit: headaches, visual disturbance, chest tightness, facial flushing, and a heavy or sluggish feeling during cardio.

Threshold: above 54% is the conventional point for intervention, because blood viscosity rises steeply and with it the risk of stroke, deep vein thrombosis, pulmonary embolism and myocardial infarction.

Baseline full blood count before the cycle. Men starting above 50% are at high risk of crossing 54%.

On cycle:

• Full blood count at week 4 and again at week 8 to 10.
• Sample at trough and normally hydrated. Dehydration falsely elevates haematocrit.
• Run haemoglobin alongside. Haemoglobin is less affected by plasma volume, so a raised haemoglobin with a borderline haematocrit should be believed rather than dismissed.

Track ferritin: Each unit of blood removed takes 200 to 250 mg of iron with it. Repeated donation across a cycle depletes iron, and the resulting fatigue is routinely misattributed to diet or overtraining.

Blood pressure at the same time: viscosity and blood pressure interact, and both matter more than either in isolation.

Post-cycle: Recheck at 6 weeks after the last injection. The short ester means haematocrit is already falling by then, unlike with decanoate.

If haematocrit is 50-54%:

• Confirm hydration and re-test before acting
• Reduce the testosterone base dose, since it is usually the larger contributor
• Keep injection frequency high. NPP is already dosed every other day, which helps
• Recheck in 4 weeks

If haematocrit exceeds 54%:

• Therapeutic phlebotomy or blood donation removes one unit and typically lowers haematocrit by 3 to 4 points
• Reduce the overall androgen load
• With the short ester, stopping NPP produces a measurable improvement within 2 to 3 weeks, which is a real advantage over decanoate

Do not treat donation as free: repeated phlebotomy depletes ferritin. Track it, and reduce the need for donation through dose management rather than relying on it.

Ester choice: If you have a haematocrit history, NPP is the more manageable of the two nandrolone esters, because the number responds when you act. That is worth more than the convenience of less frequent injections.

Further reading: How to lower haematocrit on TRT